Firms

Additio Investment Group

Additio Investment Group

additioinvestmentgroup.comlinkedin.com

Additio Investment Group, branded AiG, is an international healthcare and life-sciences investment syndicate that combines capital from industry entrepreneurs, executives and investors with operating support and professional networks. Its own current website describes emphasis on European seed and Series A opportunities in medical technology, digital health and selected biotechnology or pharmaceutical businesses, sourced mainly through internal referrals. Its public portfolio links identify Gedea Biotech, SOM Biotech, VB Devices, Oxford Endovascular, Cytovation, Leixir, Orthox, neurocare group and Gasgon Medical. This supports relevance to neuroscience devices, technology-enabled mental-health care and biotechnology; portfolio products are not represented as clinically approved solely because the manager lists them. Oxford Endovascular independently named Additio as a participant in its April8,2021 Series A, and the manager reciprocally links the issuer domain, confirming identity independently of the similarly named US firm Addition. The own website also links a LinkedIn company slug spelled additoinvestmentgroup; that spelling is a brand alias rather than a different investment entity. AiG1 is a pledge-fund structure launched in2019 and described as allocated to portfolio companies; its commitment total, individual tickets and exact closing dates are undisclosed. It is not presented as an independently verified regulated legal partnership or a conventional committed fund. Primary industry-event material identifies Spain participation and co-founder/founding partner Lourens D. Verweij, but the website does not publish a complete team roster, precise operating-company legal suffix, legal fund vehicle, or principal office address. Those fields remain unclaimed rather than inferred from namesakes or commercial databases.

Founded
—
Type
Venture capital

Funds1

  • AiG1 (Additio Investment Group Fund 1)—

Team

Operations and support

Lourens VerweijLourens VerweijCo-Founder / Founding Partner (primary published affiliation)
Raj AireyRaj AireyInvestment representative (documented 2022; current appointment unconfirmed)

Co-investing

Investments